MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma
Emily K. Slotkin
, Parag P. Patwardhan
, Shyamprasad D. Vasudeva
, Elisa De Stanchina
, William D. Tap
, Gary K. Schwartz
Research output: Contribution to journal › Article › peer-review
102Scopus
citations
Fingerprint
Dive into the research topics of 'MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in vitro and in vivo antitumor activity, as potential therapy for bone and soft-tissue sarcoma'. Together they form a unique fingerprint.
Keyphrases
Pharmacology, Toxicology and Pharmaceutical Science